Mitochondrial Dysfunction in Parkinson's Disease
Parkinson's disease (PD) is a progressive, neurodegenerative condition that has increasingly been linked with mitochondrial dysfunction and inhibition of the electron transport chain. This inhibition leads to the generation of reactive oxygen species and depletion of cellular energy levels, wh...
Saved in:
Main Authors: | P. C. Keane, M. Kurzawa, P. G. Blain, C. M. Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.4061/2011/716871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
by: David Protter, et al.
Published: (2012-01-01) -
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
by: Michela Zaltieri, et al.
Published: (2015-01-01) -
The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease
by: Kemal Ugur Tufekci, et al.
Published: (2011-01-01) -
Behavioral and Emotional Dysfunction in Parkinson’s Disease
by: Matteo Bologna, et al.
Published: (2019-01-01) -
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson’s Disease Penetrance
by: Alessandra Zanon, et al.
Published: (2018-01-01)